EXR
57
7
D
41
4
CME
56
3
FOXA
63
3
NWSA
78
5
LMT
29
2
CPB
30
5
SLG
66
4
RSG
62
2
RCL
81
4
PM
66
6
TROW
54
6
ADM
16
-9
IPG
50
2
SLB
45
4
OKE
68
4
PHM
60
6
BDX
41
3
LEN
53
3
ESS
56
5
EXR
57
7
D
41
4
CME
56
3
FOXA
63
3
NWSA
78
5
LMT
29
2
CPB
30
5
SLG
66
4
RSG
62
2
RCL
81
4
PM
66
6
TROW
54
6
ADM
16
-9
IPG
50
2
SLB
45
4
OKE
68
4
PHM
60
6
BDX
41
3
LEN
53
3
ESS
56
5
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
83

RYTM
Rhythm Pharmaceuticals

Last Price:
56.20
Seasonality Move:
9.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.43M
Cash Flow: $-69.08M
Price / Cash Flow: 0
Annual Sales: $0.64
Price / Book: 87.41

Profitability

EPS (TTM): -4.36000
Net Income (TTM): $-259.43M
Gross Margin: $68.13M
Return on Equity: -164.07%
Return on Assets: -79.22%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.53
Quick Ratio: 6.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
83
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?